Note from the Board

Dear readers, 

As we progress rapidly through the new year, we are excited to report a flurry of activity and progress from many of GloPID-R’s initiatives. Many of these are an early result of the resolutions set at last year’s general assembly. We are happy to report that this progress also reaffirms our commitment to strengthen global outbreak preparedness. We have created new working groups, Research Funding Contraction and Biosecurity, following the ongoing discussions on evolving research funding landscape.  

Additionally, we are proud to announce that GloPID-R’s work to date has been highlighted in the latest International Pandemic Preparedness Secretariat report titled, ‘100 Days Mission (100DM) Implementation Report: Progress in 2025 and Priorities for 2026’. The report recognises GloPID-R’s role in advancing the integration of global and regional clinical trials networks, and cites the launch of the Global Research Improving Pandemic Preparedness (GRIPP) initiative as an innovative and coordinated funding approach to strengthen preparedness. 

Lastly, we would like to thank Elizabeth Higgs from NIH/NIAD for her invaluable contribution as Board Member to GloPID-R as she stepped down at the end February. Her dedication and expertise have helped shape the direction of our initiatives, and we wish her all the best in her future endeavors. 

We look forward to continuing our collaborative work with members, partners, and stakeholders throughout 2026, as we advance global preparedness and strengthen the collective response to emerging infectious threats. 

Sincerely, 

The GloPID-R Board